A phase 3 randomized controlled trial of the efficacy and safety of atrasentan in men with metastatic hormone-refractory prostate cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A phase 3 randomized controlled trial of the efficacy and safety of atrasentan in men with metastatic hormone-refractory prostate cancer

Published:2007 Issue:9 Volume:110 Page:1959-1966
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Carducci Michael A.,Saad Fred,Abrahamsson Per-Anders,Dearnaley David P.,Schulman Claude C.,North Scott A.,Sleep Darryl J.,Isaacson Jeffrey D.,Nelson Joel B.,

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference35 articles.

1. Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer

2. Docetaxel and Estramustine Compared with Mitoxantrone and Prednisone for Advanced Refractory Prostate Cancer

3. Oncology, Inc. OncoTrack [database online], updated June 2005. Available at URL: http://oncologyinc.com Accessed September 5, 2007.

Cited by 257 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endothelin and the tumor microenvironment: a finger in every pie;Clinical Science;2024-05-24

2. Mechanisms Underlying Osteolytic and Osteoblastic Bone Metastases;Metastatic Bone Disease;2024

3. A Comprehensive Review of Interventional Clinical Trials in Patients with Bone Metastases;OncoTargets and Therapy;2023-06

4. Biological and Clinical Aspects of Metastatic Spinal Tumors;Cancers;2022-09-22

5. Targeting signaling pathways in prostate cancer: mechanisms and clinical trials;Signal Transduction and Targeted Therapy;2022-06-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP